Off-label use of eculizumab for neurological symptoms and progressive vision loss
We describe the results of eculizumab treatment of a patient with pachymeningitis, inflammatory infiltration of the left frontal lobe, and cerebral hematoma, who presented with progressive vision loss, epileptic seizures, and abnormal pattern of the complement system parameters. A 30-year-old female...
Main Authors: | Alicja Kuźniewska, Marta Jaskólska, Mariusz Kwarciany, Aleksandra Ciarka, Rafał Pęksa, Zbigniew Zdrojewski, Marcin Okrój |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2023-12-01
|
Series: | Folia Neuropathologica |
Subjects: | |
Online Access: | https://www.termedia.pl/Off-label-use-of-eculizumab-for-neurological-symptoms-and-progressive-vision-loss,20,52237,1,1.html |
Similar Items
-
Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option
by: Elena Román, et al.
Published: (2017-09-01) -
Carfilzomib-Induced Thrombotic Microangiopathy Treated with Eculizumab: A Case Report and Rapid Literature Review
by: Federica Pallotti, et al.
Published: (2022-12-01) -
Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Generalized Myasthenia Gravis
by: Jonathan P. R. Monteleone, et al.
Published: (2021-11-01) -
Rational use of eculizumab in secondary atypical hemolytic uremic syndrome
by: Lucía Cordero, et al.
Published: (2024-01-01) -
The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial
by: Aleksandr D. Kulagin, et al.
Published: (2021-11-01)